Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: September 2011
-
By James DeGiulio — Validity of Allergan Lumigan Patents Upheld Allergan has successfully defended its patents covering the glaucoma drug Lumigan from an invalidity attack by alleged infringers Teva and Sandoz. In May 2009, Allergan filed the suit in the District of Delaware against Teva and Barr Laboratories, alleging infringement of U.S. Patent Nos. 6,403,649…
-
By Donald Zuhn — On Monday, President Obama released his plan for economic growth and deficit reduction. The 80-page plan, entitled "Living Within Our Means and Investing in the Future," outlines how the President would pay for the proposals in the American Jobs Act, which he unveiled on September 8th. According to the President, the…
-
By Kevin E. Noonan — A little more than one year after the Supreme Court issued its opinion on the patent-eligibility of (business) method claims in Bilski v. Kappos, the Court has granted certiorari in one case (Prometheus Laboratories, Inc. v. Mayo Collaborative Services) and may consider two others (Classen Immunotherapies, Inc. v. Biogen Idec. and…
-
By Donald Zuhn — On Friday, President Obama signed the Leahy-Smith America Invents Act (H.R. 1249) into law. In a press release issued after the signing, the White House said the legislation would "help American entrepreneurs and businesses bring their inventions to market sooner, creating new businesses and new jobs." President Obama noted that he…
-
On Friday, the Federal Circuit (presumably) denied Defendants' petition for panel rehearing in Association for Molecular Pathology v. U.S. Patent and Trademark Office. Unlike the Court's earlier notice regarding denial of Plaintiffs'/Appellees' petition, this notice did not identify the party (but Defendants' petition was the only one pending). In their petition, counsel for Defendants asserted…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Takeda Pharmaceutical Co. et al. v. Accord Healthcare, Inc.1:11-cv-06360; filed September 12, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.• Defendant: Accord Healthcare, Inc. Infringement…
-
September 19-20, 2011 – Tech Transfer Summit Europe*** (Tech Transfer Summit Ltd.) – Paris, France September 19-21, 2011 – Business of Biosimilars & Biobetters*** (Institute for International Research) – Boston, MA September 21-22, 2011 – Forum on European Pharmaceutical Regulatory Law*** (C5) – Brussels, Belgium September 22-23, 2011 – FDA Boot Camp*** (American Conference Institute)…
-
American Conference Institute (ACI) will be holding its next Paragraph IV Disputes conference on December 6-7, 2011 in San Francisco, CA. The conference will allow attendees to: • Pinpoint patents that may be vulnerable to a Paragraph IV challenge;• Demystify an ANDA applicant's Orange Book strategy and dissecting a challenger's obligations under Paragraph IV;• Understand…
-
Technology Transfer Tactics will be offering a two-part webinar providing "Patent Reform: Impact and Strategy for University Research and Tech Transfer" on October 14, 2011 from 1:00 – 5:00 PM (Eastern). Charles Macedo of Amster, Rothstein and Ebenstein, LLP; Patent Docs author Dr. Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP; Randi Isaacs, In-House…
-
Strafford will be offering a webinar entitled "USPTO Post-Grant Proceedings After New Patent Reform Law" on September 28, 2011 from 1:00 – 2:30 PM (EDT). Scott McKeown of Oblon Spivak McClelland Maier & Neustadt and Kevin Laurence of Stoel Rives will provide guidance for counsel to IP owners and inventors on the new America Invents…
Patent Docs 